Loading...
ICSBP-mediated immune protection against BCR-ABL–induced leukemia requires the CCL6 and CCL9 chemokines
Interferon (IFN) is effective at inducing complete remissions in patients with chronic myelogenous leukemia (CML), and evidence supports an immune mechanism. Here we show that the type I IFNs (alpha and beta) regulate expression of the IFN consensus sequence-binding protein (ICSBP) in BCR-ABL–transf...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2670796/ https://ncbi.nlm.nih.gov/pubmed/19171873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-07-167189 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|